CYP19A1 and neoplasm: PRI‐2191 or PRI‐2205 (non‐calcemic vitamin D analogs) potentiated the antitumor effects of the aromatase inhibitor anastrazole in MCF‐7 tumor‐bearing mice. The combination treatment reduced aromatase gene expression and activity and downregulated ER expression.